Vimta Labs Limited
Vimta Labs: 40+ years of scientific excellence in preclinical solutions.
We provide comprehensive services—DMPK, toxicology, safety pharmacology, and genetic toxicology—supporting IND and NDA submissions across small molecules, biologics, ADCs, peptides, and protein degraders.
Our advanced preclinical models include rodents and non-rodents such as Mice, Rats, Beagle Dogs, and Göttingen Minipigs, offering reliable and relevant data.
Operating from a 120,000 sq. ft. GLP-certified, AAALAC-accredited, and USFDA-inspected facility, we ensure top-quality and compliance.
Our expert PhD team combines scientific rigor with agile project management for timely, high-integrity results. With 24+ successful IND programs in 6 years, Vimta Labs is your trusted partner to accelerate drug development efficiently and confidently.